| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $83.6M | — | +12.3% |
| SG&A Expense | $35.8M | — | +75.5% |
| Operating Income | -$119.4M | — | -25.9% |
| Pre-tax Income | -$109.1M | — | -29.2% |
| Income Tax | $168K | — | +7.0% |
| Net Income | -$109.3M | — | -29.2% |
| EPS (Basic) | -$1.39 | — | -17.8% |
| EPS (Diluted) | -$1.39 | — | -17.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $159.7M | -39.0% | +32.2% |
| Short-term Investments | $1.13B | +1.6% | +18.4% |
| Current Assets | $1.31B | -6.1% | +20.4% |
| Total Assets | $1.33B | -5.8% | +20.4% |
| Current Liabilities | $81.1M | -11.1% | +8.0% |
| Total Liabilities | $156.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$92.4M | — | -68.5% |
| Investing Cash Flow | -$19.4M | — | -176.4% |
| Financing Cash Flow | $9.8M | — | +115.5% |
| +65.5% |
| Stockholders' Equity | $1.17B | -5.9% | +16.2% |